Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danlou Tablet for CAD Not Amenable to Revascularization
NCT03072082Phase 4Unknown
- Start
- Jun 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of danlou tablet + salvia miltiorrhiza + ligustrazine in coronary artery disease (CAD). Status: unknown.
02
Drugs
danlou tablet + salvia miltiorrhiza + ligustrazine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03072082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03072082.